161 related articles for article (PubMed ID: 7687120)
1. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.
Kovacs JA; Powell F; Voeller D; Allegra CJ
Antimicrob Agents Chemother; 1993 Jun; 37(6):1227-31. PubMed ID: 7687120
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).
Voeller D; Kovacs J; Andrawis V; Chu E; Masur H; Allegra C
J Infect Dis; 1994 Feb; 169(2):456-9. PubMed ID: 8106784
[TBL] [Abstract][Full Text] [Related]
3. Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.
Chio LC; Bolyard LA; Nasr M; Queener SF
Antimicrob Agents Chemother; 1996 Mar; 40(3):727-33. PubMed ID: 8851601
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
Hong YL; Hossler PA; Calhoun DH; Meshnick SR
Antimicrob Agents Chemother; 1995 Aug; 39(8):1756-63. PubMed ID: 7486915
[TBL] [Abstract][Full Text] [Related]
5. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
Merali S; Zhang Y; Sloan D; Meshnick S
Antimicrob Agents Chemother; 1990 Jun; 34(6):1075-8. PubMed ID: 2203302
[TBL] [Abstract][Full Text] [Related]
7. p-Aminobenzoic acid, but not its metabolite p-acetamidobenzoic acid, inhibits thrombin induced thromboxane formation in human platelets in a non NSAID like manner.
Barbieri B; Papadogiannakis N; Eneroth P; Söderstedt A; Stain-Malmgren R; Olding LB
Thromb Res; 1997 Apr; 86(2):127-40. PubMed ID: 9175234
[TBL] [Abstract][Full Text] [Related]
8. p-Aminobenzoic acid and its metabolite p-acetamidobenzoic acid inhibit agonist-induced aggregation and arachidonic acid-induced [Ca2+]i transients in human platelets.
Barbieri B; Stain-Malmgren R; Papadogiannakis N
Thromb Res; 1999 Sep; 95(5):235-43. PubMed ID: 10515288
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
Rosowsky A; Papoulis AT; Forsch RA; Queener SF
J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
[TBL] [Abstract][Full Text] [Related]
10. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2004 Jul; 48(7):2617-23. PubMed ID: 15215118
[TBL] [Abstract][Full Text] [Related]
11. Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agents.
Kovacs JA; Allegra CJ; Beaver J; Boarman D; Lewis M; Parrillo JE; Chabner B; Masur H
J Infect Dis; 1989 Aug; 160(2):312-20. PubMed ID: 2527275
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of dihydropteroate polymorphism in AIDS-related Pneumocystis carinii pneumonia by restriction fragment length polymorphism.
Helweg-Larsen J; Eugen-Olsen J; Lundgren B
Scand J Infect Dis; 2000; 32(5):481-3. PubMed ID: 11055650
[TBL] [Abstract][Full Text] [Related]
13. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
Navin TR; Beard CB; Huang L; del Rio C; Lee S; Pieniazek NJ; Carter JL; Le T; Hightower A; Rimland D
Lancet; 2001 Aug; 358(9281):545-9. PubMed ID: 11520525
[TBL] [Abstract][Full Text] [Related]
14. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia.
Visconti E; Ortona E; Mencarini P; Margutti P; Marinaci S; Zolfo M; Siracusano A; Tamburrini E
Int J Antimicrob Agents; 2001 Dec; 18(6):547-51. PubMed ID: 11738342
[TBL] [Abstract][Full Text] [Related]
15. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
Takahashi T; Hosoya N; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Nakamura Y; Iwamoto A
J Clin Microbiol; 2000 Sep; 38(9):3161-4. PubMed ID: 10970350
[TBL] [Abstract][Full Text] [Related]
16. P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
Thijssen HH
J Med Chem; 1977 Feb; 20(2):233-6. PubMed ID: 319235
[TBL] [Abstract][Full Text] [Related]
17. 6,7-disubstituted 2,4-diaminopteridines: novel inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
Jackson HC; Biggadike K; McKilligin E; Kinsman OS; Queener SF; Lane A; Smith JE
Antimicrob Agents Chemother; 1996 Jun; 40(6):1371-5. PubMed ID: 8726003
[TBL] [Abstract][Full Text] [Related]
18. Linking Pneumocystis jiroveci sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae.
Moukhlis R; Boyer J; Lacube P; Bolognini J; Roux P; Hennequin C
Clin Microbiol Infect; 2010 May; 16(5):501-7. PubMed ID: 19673964
[TBL] [Abstract][Full Text] [Related]
19. Microculture screening assay for primary in vitro evaluation of drugs against Pneumocystis carinii.
Comley JC; Mullin RJ; Wolfe LA; Hanlon MH; Ferone R
Antimicrob Agents Chemother; 1991 Oct; 35(10):1965-74. PubMed ID: 1759815
[TBL] [Abstract][Full Text] [Related]
20. Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia.
Walzer PD; Foy J; Steele P; Kim CK; White M; Klein RS; Otter BA; Allegra C
Antimicrob Agents Chemother; 1992 Sep; 36(9):1935-42. PubMed ID: 1416884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]